Maria Areli Lorenzana-Carrillo

4PUBLICATIONS

13CO-AUTHORS

Molecular targetsHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Apr 15, 2026

Selective translation of ZNF281 as part of the integrated stress response system has therapeutic relevance for cardio-oncology.

|Jul 27, 2025

Tumour initiated purinergic signalling promotes cardiomyocyte RBFOX1 degradation and cardiotoxicity from DNA damaging anticancer agents.

Saymon Tejay, Maria Areli Lorenzana-Carrillo, Guocheng Huang

|Jun 11, 2024

TRIM35 Monoubiquitinates H2B in Cardiac Cells, Implications for Heart Failure.

Maria Areli Lorenzana-Carrillo, Saymon Tejay, Joseph Nanoa

|Nov 02, 2022

TRIM35-mediated degradation of nuclear PKM2 destabilizes GATA4/6 and induces P53 in cardiomyocytes to promote heart failure.

Maria Areli Lorenzana-Carrillo, Keshav Gopal, Nikole J Byrne

Pageof 1

Frequent Collaborators

4 joint publications

Michelle Mendiola Pla

4 joint publications

Evangelos D Michelakis

4 joint publications

Gopinath Sutendra

3 joint publications

Saymon Tejay

2 joint publications

Alois Haromy

2 joint publications

Dawn E Bowles

2 joint publications

Joseph Nanoa

1 joint publications

Bruno Saleme

1 joint publications

Yongneng Zhang

1 joint publications

Seyed Amirhossein Tabatabaei Dakhili

Frequent Collaborators

4 joint publications

Michelle Mendiola Pla

4 joint publications

Evangelos D Michelakis

4 joint publications

Gopinath Sutendra

3 joint publications

Saymon Tejay